Cancer Genetics, NovellusDx Sign Merger Agreement

Cancer Genetics (CGI) and NovellusDx announced today that they have agreed to merge.

The transaction will combine CGI’s portfolio of cancer tests and laboratory service offerings with NovellusDx’s next-generation sequencing and machine-learning technologies for cancer treatment response prediction.

Source: https://www.genomeweb.com/molecular-diagnostics/cancer-genetics-novellusdx-sign-merger-agreement?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Tues%20AM%202018-09-18&utm_term=GW%20Daily%20News%20Bulletin